abnormal bone mineralization_Lmna<tm1Lgf>/Lmna<+>

http://metadb.riken.jp/0002896I129P2OlaHsdC57BL6Lmnatm1LgfLmnaLmnatm1LgfLmna

abnormal bone mineralization_Lmna<tm1Lgf>/Lmna<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• lamin A
  http://metadb.riken.jp/db/mgi_rdf/MGI:96794

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Lmna<tm1Lgf>/Lmna<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Lmna<tm1Lgf>|Lmna<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal bone mineralization
  http://purl.obolibrary.org/obo/MP_0002896

文献

http://purl.org/net/cito/citesAsAuthority

• Shao H. Yang, et.al., A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation., The Journal of clinical investigation, 2006, 116
  http://rdf.ncbi.nlm.nih.gov/pubmed/16862216